Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus.
Identifieur interne : 000125 ( PubMed/Curation ); précédent : 000124; suivant : 000126Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus.
Auteurs : Joseph M. Kheir [États-Unis] ; Carla J. Guthridge [États-Unis] ; Jonathon R. Johnston [États-Unis] ; Lucas J. Adams [États-Unis] ; Astrid Rasmussen [États-Unis] ; Timothy F. Gross [États-Unis] ; Melissa E. Munroe [États-Unis] ; Rebecka L. Bourn [États-Unis] ; Kathy L. Sivils [États-Unis] ; Joel M. Guthridge [États-Unis] ; Michael H. Weisman [États-Unis] ; Daniel J. Wallace [États-Unis] ; Juan-Manuel Anaya [Colombie] ; Adriana Rojas Villarraga [Colombie] ; James N. Jarvis [États-Unis] ; John B. Harley [États-Unis] ; Judith A. James [États-Unis]Source :
- Lupus science & medicine [ 2053-8790 ] ; 2018.
Abstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with varied morbidity and mortality. We assessed clinical presentations, autoantibody specificities and therapeutic interventions in Native American (NA) patients with SLE.
DOI: 10.1136/lupus-2017-000247
PubMed: 29531773
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000125
Links to Exploration step
pubmed:29531773Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus.</title><author><name sortKey="Kheir, Joseph M" sort="Kheir, Joseph M" uniqKey="Kheir J" first="Joseph M" last="Kheir">Joseph M. Kheir</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Guthridge, Carla J" sort="Guthridge, Carla J" uniqKey="Guthridge C" first="Carla J" last="Guthridge">Carla J. Guthridge</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Johnston, Jonathon R" sort="Johnston, Jonathon R" uniqKey="Johnston J" first="Jonathon R" last="Johnston">Jonathon R. Johnston</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Adams, Lucas J" sort="Adams, Lucas J" uniqKey="Adams L" first="Lucas J" last="Adams">Lucas J. Adams</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Rasmussen, Astrid" sort="Rasmussen, Astrid" uniqKey="Rasmussen A" first="Astrid" last="Rasmussen">Astrid Rasmussen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Gross, Timothy F" sort="Gross, Timothy F" uniqKey="Gross T" first="Timothy F" last="Gross">Timothy F. Gross</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Munroe, Melissa E" sort="Munroe, Melissa E" uniqKey="Munroe M" first="Melissa E" last="Munroe">Melissa E. Munroe</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Bourn, Rebecka L" sort="Bourn, Rebecka L" uniqKey="Bourn R" first="Rebecka L" last="Bourn">Rebecka L. Bourn</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Sivils, Kathy L" sort="Sivils, Kathy L" uniqKey="Sivils K" first="Kathy L" last="Sivils">Kathy L. Sivils</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Guthridge, Joel M" sort="Guthridge, Joel M" uniqKey="Guthridge J" first="Joel M" last="Guthridge">Joel M. Guthridge</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Weisman, Michael H" sort="Weisman, Michael H" uniqKey="Weisman M" first="Michael H" last="Weisman">Michael H. Weisman</name><affiliation wicri:level="1"><nlm:affiliation>Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California</wicri:regionArea></affiliation></author><author><name sortKey="Wallace, Daniel J" sort="Wallace, Daniel J" uniqKey="Wallace D" first="Daniel J" last="Wallace">Daniel J. Wallace</name><affiliation wicri:level="1"><nlm:affiliation>Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California</wicri:regionArea></affiliation></author><author><name sortKey="Anaya, Juan Manuel" sort="Anaya, Juan Manuel" uniqKey="Anaya J" first="Juan-Manuel" last="Anaya">Juan-Manuel Anaya</name><affiliation wicri:level="1"><nlm:affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.</nlm:affiliation><country xml:lang="fr">Colombie</country><wicri:regionArea>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá</wicri:regionArea></affiliation></author><author><name sortKey="Rojas Villarraga, Adriana" sort="Rojas Villarraga, Adriana" uniqKey="Rojas Villarraga A" first="Adriana" last="Rojas Villarraga">Adriana Rojas Villarraga</name><affiliation wicri:level="1"><nlm:affiliation>Artmedica IPS, Bogotá, Colombia.</nlm:affiliation><country xml:lang="fr">Colombie</country><wicri:regionArea>Artmedica IPS, Bogotá</wicri:regionArea></affiliation></author><author><name sortKey="Jarvis, James N" sort="Jarvis, James N" uniqKey="Jarvis J" first="James N" last="Jarvis">James N. Jarvis</name><affiliation wicri:level="1"><nlm:affiliation>Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York</wicri:regionArea></affiliation></author><author><name sortKey="Harley, John B" sort="Harley, John B" uniqKey="Harley J" first="John B" last="Harley">John B. Harley</name><affiliation wicri:level="1"><nlm:affiliation>Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio</wicri:regionArea></affiliation></author><author><name sortKey="James, Judith A" sort="James, Judith A" uniqKey="James J" first="Judith A" last="James">Judith A. James</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29531773</idno><idno type="pmid">29531773</idno><idno type="doi">10.1136/lupus-2017-000247</idno><idno type="wicri:Area/PubMed/Corpus">000125</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000125</idno><idno type="wicri:Area/PubMed/Curation">000125</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000125</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus.</title><author><name sortKey="Kheir, Joseph M" sort="Kheir, Joseph M" uniqKey="Kheir J" first="Joseph M" last="Kheir">Joseph M. Kheir</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Guthridge, Carla J" sort="Guthridge, Carla J" uniqKey="Guthridge C" first="Carla J" last="Guthridge">Carla J. Guthridge</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Johnston, Jonathon R" sort="Johnston, Jonathon R" uniqKey="Johnston J" first="Jonathon R" last="Johnston">Jonathon R. Johnston</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Adams, Lucas J" sort="Adams, Lucas J" uniqKey="Adams L" first="Lucas J" last="Adams">Lucas J. Adams</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Rasmussen, Astrid" sort="Rasmussen, Astrid" uniqKey="Rasmussen A" first="Astrid" last="Rasmussen">Astrid Rasmussen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Gross, Timothy F" sort="Gross, Timothy F" uniqKey="Gross T" first="Timothy F" last="Gross">Timothy F. Gross</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Munroe, Melissa E" sort="Munroe, Melissa E" uniqKey="Munroe M" first="Melissa E" last="Munroe">Melissa E. Munroe</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Bourn, Rebecka L" sort="Bourn, Rebecka L" uniqKey="Bourn R" first="Rebecka L" last="Bourn">Rebecka L. Bourn</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Sivils, Kathy L" sort="Sivils, Kathy L" uniqKey="Sivils K" first="Kathy L" last="Sivils">Kathy L. Sivils</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Guthridge, Joel M" sort="Guthridge, Joel M" uniqKey="Guthridge J" first="Joel M" last="Guthridge">Joel M. Guthridge</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author><author><name sortKey="Weisman, Michael H" sort="Weisman, Michael H" uniqKey="Weisman M" first="Michael H" last="Weisman">Michael H. Weisman</name><affiliation wicri:level="1"><nlm:affiliation>Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California</wicri:regionArea></affiliation></author><author><name sortKey="Wallace, Daniel J" sort="Wallace, Daniel J" uniqKey="Wallace D" first="Daniel J" last="Wallace">Daniel J. Wallace</name><affiliation wicri:level="1"><nlm:affiliation>Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California</wicri:regionArea></affiliation></author><author><name sortKey="Anaya, Juan Manuel" sort="Anaya, Juan Manuel" uniqKey="Anaya J" first="Juan-Manuel" last="Anaya">Juan-Manuel Anaya</name><affiliation wicri:level="1"><nlm:affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.</nlm:affiliation><country xml:lang="fr">Colombie</country><wicri:regionArea>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá</wicri:regionArea></affiliation></author><author><name sortKey="Rojas Villarraga, Adriana" sort="Rojas Villarraga, Adriana" uniqKey="Rojas Villarraga A" first="Adriana" last="Rojas Villarraga">Adriana Rojas Villarraga</name><affiliation wicri:level="1"><nlm:affiliation>Artmedica IPS, Bogotá, Colombia.</nlm:affiliation><country xml:lang="fr">Colombie</country><wicri:regionArea>Artmedica IPS, Bogotá</wicri:regionArea></affiliation></author><author><name sortKey="Jarvis, James N" sort="Jarvis, James N" uniqKey="Jarvis J" first="James N" last="Jarvis">James N. Jarvis</name><affiliation wicri:level="1"><nlm:affiliation>Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York</wicri:regionArea></affiliation></author><author><name sortKey="Harley, John B" sort="Harley, John B" uniqKey="Harley J" first="John B" last="Harley">John B. Harley</name><affiliation wicri:level="1"><nlm:affiliation>Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio</wicri:regionArea></affiliation></author><author><name sortKey="James, Judith A" sort="James, Judith A" uniqKey="James J" first="Judith A" last="James">Judith A. James</name><affiliation wicri:level="1"><nlm:affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma</wicri:regionArea></affiliation></author></analytic><series><title level="j">Lupus science & medicine</title><idno type="ISSN">2053-8790</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with varied morbidity and mortality. We assessed clinical presentations, autoantibody specificities and therapeutic interventions in Native American (NA) patients with SLE.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29531773</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Lupus science & medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus.</ArticleTitle><Pagination><MedlinePgn>e000247</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2017-000247</ELocationID><Abstract><AbstractText Label="Objective" NlmCategory="UNASSIGNED">Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with varied morbidity and mortality. We assessed clinical presentations, autoantibody specificities and therapeutic interventions in Native American (NA) patients with SLE.</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">Patients with SLE meeting 1997 American College of Rheumatology classification criteria (n=3148) were enrolled between 1992 and 2010 in the multiethnic, cross-sectional Lupus Family Registry and Repository. Clinical, demographic and therapeutic information were extracted from medical records using a standardised form and formalised training. Autoantibodies were assessed by indirect immunofluorescence (antinuclear antibodies (ANA) and antidouble-stranded DNA), precipitin (ENA) and ELISA (IgG and IgM anticardiolipins).</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">NA patients met SLE classification at a younger age (29.89±12.3 years) than European Americans (EA; 32.02±12.87, P=0.0157) and a similar age to African-Americans (AAs) and Hispanics (HIS). More NA patients had concurrent rheumatic diseases or symptoms, such as Raynaud's phenomenon, interstitial lung disease, Sjӧgren's syndrome and systemic sclerosis. Compared with EAs, NAs were more likely to have high-titre ANA (≥1:3240; P<0.0001) and had more SLE-associated autoantibodies. Autoantibodies with unknown specificities were more common in NAs (41%) compared with other racial/ethnic groups in this collection (AA: 24%, P=0.0006; EA: 17%, P<0.0001; HIS: 23%, P=0.0050). Fewer NA patients used hydroxychloroquine (68%) compared with others (AA: 74%, P=0.0308; EA: 79%, P=0.0001, HIS: 77%, P=0.0173); this was influenced by lower hydroxychloroquine use in NA patients from Latin America (32%). NA patients had higher rates of methotrexate use (28%) compared with AA (18%, P=0.0006) and HIS patients (14%, P=0.0003), higher azathioprine use (38%) compared with EA patients (30%, P=0.0105) and higher mycophenolate mofetil use (26%) compared with EA (17%, P=0.0012) and HIS patients (11%, P<0.0001).</AbstractText><AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">NA patients are diagnosed with SLE earlier in life and present worse concurrent rheumatic disease symptoms than EA patients. NA patients also are more likely to have expanded autoantibody profiles and precipitins of unknown specificities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kheir</LastName><ForeName>Joseph M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guthridge</LastName><ForeName>Carla J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Jonathon R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oklahoma State University Health Sciences Center, Tulsa, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Lucas J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Astrid</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7744-2948</Identifier><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gross</LastName><ForeName>Timothy F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munroe</LastName><ForeName>Melissa E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourn</LastName><ForeName>Rebecka L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivils</LastName><ForeName>Kathy L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guthridge</LastName><ForeName>Joel M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weisman</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anaya</LastName><ForeName>Juan-Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas Villarraga</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Artmedica IPS, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarvis</LastName><ForeName>James N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harley</LastName><ForeName>John B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>US Department of Veterans Affairs Medical Center, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Judith A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI082714</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AI130830</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 GM103510</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR053483</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AI101934</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI024717</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008666</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antinuclear antibodies (ANA)</Keyword><Keyword MajorTopicYN="N">autoantibodies</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus (SLE)</Keyword></KeywordList><CoiStatement>Competing interests: AR reports personal fees from ThermoFisher for talks regarding diagnosis and classification of Sjögren’s syndrome and the different autoantibody testing platforms.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29531773</ArticleId><ArticleId IdType="doi">10.1136/lupus-2017-000247</ArticleId><ArticleId IdType="pii">lupus-2017-000247</ArticleId><ArticleId IdType="pmc">PMC5844376</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthritis Rheum. 1997 Sep;40(9):1725</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2011 Jan;50(1):47-59</Citation><ArticleIdList><ArticleId IdType="pubmed">20864496</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pulm Med. 2000 Sep;6(5):424-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10958234</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rheumatol. 1990 Mar;9(1 Suppl 1):82-94</Citation><ArticleIdList><ArticleId IdType="pubmed">2203596</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2017 Apr;69(4):467-474</Citation><ArticleIdList><ArticleId IdType="pubmed">27333120</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1978 May;21(4):473-9</Citation><ArticleIdList><ArticleId IdType="pubmed">656162</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 2006 Feb;96(2):363-70</Citation><ArticleIdList><ArticleId IdType="pubmed">16257948</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2012 Oct;39(10):1934-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22896022</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2013 Dec;13(6):814-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24037313</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2014 Sep;66(9):2494-502</Citation><ArticleIdList><ArticleId IdType="pubmed">24891315</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2000 Aug;27(8):1884-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10955328</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2007 May 15;57(4):601-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17471527</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1992 Jun;35(6):630-40</Citation><ArticleIdList><ArticleId IdType="pubmed">1599520</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2004 Jan;83(1):1-17</Citation><ArticleIdList><ArticleId IdType="pubmed">14747764</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2016 Nov;74:182-193</Citation><ArticleIdList><ArticleId IdType="pubmed">27338520</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2014 Jul;66(7):1888-99</Citation><ArticleIdList><ArticleId IdType="pubmed">24578190</ArticleId></ArticleIdList></Reference><Reference><Citation>Q J Med. 1990 Mar;74(275):319-30</Citation><ArticleIdList><ArticleId IdType="pubmed">2385739</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1982 Nov;25(11):1271-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2008;1136:126-36</Citation><ArticleIdList><ArticleId IdType="pubmed">18579879</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2017 Aug;69(8):1271-1275</Citation><ArticleIdList><ArticleId IdType="pubmed">27788293</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 1999 Jun;28(6):368-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10406405</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 1988 Apr;15(4):684-90</Citation><ArticleIdList><ArticleId IdType="pubmed">3260954</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1999 Mar;42(3):465-74</Citation><ArticleIdList><ArticleId IdType="pubmed">10088769</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1996 Feb;39(2):283-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8849380</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2012 Jan;64(1):138-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21972194</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2015 Mar;67(3):752-60</Citation><ArticleIdList><ArticleId IdType="pubmed">25590668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2007 Sep;66(9):1168-72</Citation><ArticleIdList><ArticleId IdType="pubmed">17389655</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000125 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000125 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:29531773
|texte= Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:29531773" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |